search
Back to results

CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients (CORTERAS)

Primary Purpose

Inflammatory Response, Weakness, Muscle

Status
Recruiting
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
Methylprednisolone
NaCl 0.9%
Sponsored by
Ziekenhuis Oost-Limburg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inflammatory Response

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 60 years or older.
  • Scheduled for one of the predefined surgical procedures:

    • off-pump coronary bypass surgery
    • on-pump coronary bypass surgery
    • aortic valve replacement
    • laparoscopic hemicolectomies
    • thoracoscopic lung resections
    • femoral popliteal and tibial bypass surgery
    • laparoscopic radical prostatectomies

Exclusion Criteria:

  • Lack of informed consent or inability to give informed consent.
  • Severe postoperative nausea & vomiting (PONV), needing corticosteroids as PONV prophylaxis.
  • Urgent, not elective surgery
  • Hypersensitivity or known allergic reactions to methylprednisolone
  • Preoperative systemic use of steroids:

    • Including, but not limited to, the use of corticosteroids > 4 weeks before surgery of at least 4 mg methylprednisolone equivalents.
    • Excluding inhalational and topical steroids
  • Preexisting muscle disease o Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.

Sites / Locations

  • Ziekenhuis Oost-LimburgRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Methylprednisolone

Arm Description

100 ml of NaCl 0,9%, not containing corticosteroids, given at induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 100 ml of NaCl 0,9% will be administered at the beginning of CPB.

250 mg of methylprednisolone made up with 100 ml NaCl 0,9%, given at the induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 250 mg methylprednisolone will be administered at the beginning of CPB.

Outcomes

Primary Outcome Measures

Post operative muscle weakness
decrease in muscle strength post-operatively, assessed by comparing the handgrip strength of the dominant hand, measured by the JAMAR dynamometer, on day 1 following surgery as compared to the preoperative value

Secondary Outcome Measures

Post operative muscle weakness
Decrease in muscle strength post-operatively, assessed by comparing the handgrip strength of the dominant hand, measured by the JAMAR dynamometer, on day 3 and 5 following surgery as compared to the preoperative value, if still in the hospital.
Maximum inspiratory pressure as measure of respiratory muscle function
Maximum inspiratory pressure on day 1, 3 and 5, as compared to pre-operative value, if still in the hospital.
Post operative fatigue
Assessed by the Chalder fatigue Questionnaire - 11 items, scores min 0 - max 33, higher score means worse outcome: post-operative day 1, 3, 5 and 28, as compared to preoperatively
Quality of recovery (QOR)
Assessed by the QOR-15 scale, scores min 0 - max 150, higher score means worse outcome, assessed on day 1, 3 and 5 as compared to preoperatively
Functioning at day 28
EuroQol five dimensions of health (EQ5D), score of 1-5 on each health dimension, higher score means worse outcome + visual analogue scale from 0-100 questionning todays health, lower score means worse outcome. EQ5D is assessed on day 28, as compared to pre-operatively values
Coagulation disorder
biochemical markers of coagulation postoperatively as compared to preoperatively
Sleeping pattern
Assessed by the Consensus Sleep Diary (CSD) in a subset of study population
Sleep quality
Assessed by the Pittsburgh Sleep Quality Index (PSQI) in a subet of study population, score range between 0 and 21, higher scores indicate worse sleep quality
Sleep chronotype
Assessed by the Munich Chronotype Questionnaire (MCTQ) is a subset of study population
Sleeping EEG pattern
Assessed by EEG recording in a subset of study population

Full Information

First Posted
January 31, 2022
Last Updated
January 25, 2023
Sponsor
Ziekenhuis Oost-Limburg
search

1. Study Identification

Unique Protocol Identification Number
NCT05220319
Brief Title
CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients
Acronym
CORTERAS
Official Title
CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 3, 2022 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ziekenhuis Oost-Limburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
Major surgery induces a systemic inflammatory response, which can influence the post-operative morbidity, such as coagulation disorders and post-operative muscle weakness, hampering early recovery after surgery. Single administration of high dose corticosteroids is known to reduce this inflammatory response and could possibly improve the post-operative outcome. The CORTERAS study will evaluate the effect of administration of corticosteroids, as compared to no corticosteroids, on postoperative muscle weakness and quality of recovery after surgery in elderly patients.
Detailed Description
The number of elderly patients undergoing surgery is expected to increase in the coming years, due to the increase in life expectancy in the developing world. Compared to younger surgical patients, the older patients are at greater risk of mortality and morbidity after surgery. Post-operative fatigue is an important complication after surgery. Not only is it reported by patients as one of the most distressing symptoms, it is also thought to be a significant contributor to delayed recovery after surgery. From a pathophysiological point of view, muscle weakness could be a major contributor to this post-operative fatigue. Recent studies showed a profound reduction in muscle strength after surgery in elderly patients, which lasted for more than 3 months after surgery. This decrease in muscle strength might be induced by an excessive inflammatory response to surgery. Glucocorticosteroids are capable of tampering an excessive inflammatory response to surgery and could improve the quality of recovery after surgery. However, a possible effect on post-operative muscle weakness hasn't been specifically investigated. Therefore, the main objective of this prospective clinical trial is to evaluate the effect of corticosteroids on early post-operative outcome, focusing on muscle weakness, in elderly patients (≥60 years) undergoing surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammatory Response, Weakness, Muscle

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
672 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
100 ml of NaCl 0,9%, not containing corticosteroids, given at induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 100 ml of NaCl 0,9% will be administered at the beginning of CPB.
Arm Title
Methylprednisolone
Arm Type
Active Comparator
Arm Description
250 mg of methylprednisolone made up with 100 ml NaCl 0,9%, given at the induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 250 mg methylprednisolone will be administered at the beginning of CPB.
Intervention Type
Drug
Intervention Name(s)
Methylprednisolone
Intervention Description
250 mg Methylprednisolone made up with 100 ml NaCl0,9% as an IV injection at the induction of anaesthesia but before surgery. If CPB is required an additional dose in 100 ml will be given.
Intervention Type
Drug
Intervention Name(s)
NaCl 0.9%
Intervention Description
100 ml NaCl0,9% as an IV injection at the induction of anaesthesia but before surgery. If CPB is required an additional 100ml will be given.
Primary Outcome Measure Information:
Title
Post operative muscle weakness
Description
decrease in muscle strength post-operatively, assessed by comparing the handgrip strength of the dominant hand, measured by the JAMAR dynamometer, on day 1 following surgery as compared to the preoperative value
Time Frame
Pre-operative and Post operative day 1
Secondary Outcome Measure Information:
Title
Post operative muscle weakness
Description
Decrease in muscle strength post-operatively, assessed by comparing the handgrip strength of the dominant hand, measured by the JAMAR dynamometer, on day 3 and 5 following surgery as compared to the preoperative value, if still in the hospital.
Time Frame
Pre-operative and Post operative day 1, 3 and 5
Title
Maximum inspiratory pressure as measure of respiratory muscle function
Description
Maximum inspiratory pressure on day 1, 3 and 5, as compared to pre-operative value, if still in the hospital.
Time Frame
Pre-operative and Post operative day 1, 3 and 5
Title
Post operative fatigue
Description
Assessed by the Chalder fatigue Questionnaire - 11 items, scores min 0 - max 33, higher score means worse outcome: post-operative day 1, 3, 5 and 28, as compared to preoperatively
Time Frame
Pre-operative and Post operative day 1, 3, 5 and 28
Title
Quality of recovery (QOR)
Description
Assessed by the QOR-15 scale, scores min 0 - max 150, higher score means worse outcome, assessed on day 1, 3 and 5 as compared to preoperatively
Time Frame
Post operative day 1, 3 and 5
Title
Functioning at day 28
Description
EuroQol five dimensions of health (EQ5D), score of 1-5 on each health dimension, higher score means worse outcome + visual analogue scale from 0-100 questionning todays health, lower score means worse outcome. EQ5D is assessed on day 28, as compared to pre-operatively values
Time Frame
Pre-operative and Post operative day 28
Title
Coagulation disorder
Description
biochemical markers of coagulation postoperatively as compared to preoperatively
Time Frame
postoperatively first 24 hours
Title
Sleeping pattern
Description
Assessed by the Consensus Sleep Diary (CSD) in a subset of study population
Time Frame
10 consecutive nights, starting 3 days before surgery
Title
Sleep quality
Description
Assessed by the Pittsburgh Sleep Quality Index (PSQI) in a subet of study population, score range between 0 and 21, higher scores indicate worse sleep quality
Time Frame
3 days before and 10 days after surgery
Title
Sleep chronotype
Description
Assessed by the Munich Chronotype Questionnaire (MCTQ) is a subset of study population
Time Frame
3 days before surgery
Title
Sleeping EEG pattern
Description
Assessed by EEG recording in a subset of study population
Time Frame
first postoperative night

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 60 years or older. Scheduled for one of the predefined surgical procedures: off-pump coronary bypass surgery on-pump coronary bypass surgery aortic and mitral valve replacement laparoscopic hemicolectomies thoracoscopic lung resections femoral popliteal and tibial bypass surgery and femoral profundoplasty laparoscopic radical prostatectomies Exclusion Criteria: Lack of informed consent or inability to give informed consent. Severe postoperative nausea & vomiting (PONV), needing corticosteroids as PONV prophylaxis. Urgent, not elective surgery Hypersensitivity or known allergic reactions to methylprednisolone Preoperative systemic use of steroids: Including, but not limited to, the use of corticosteroids > 4 weeks before surgery of at least 4 mg methylprednisolone equivalents. Excluding inhalational and topical steroids Preexisting muscle disease o Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
STEVEN THIESSEN
Phone
003289325294
Email
steven.thiessen@zol.be
Facility Information:
Facility Name
Ziekenhuis Oost-Limburg
City
Genk
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven Thiessen
Phone
89325294
Email
steven.thiessen@zol.be

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients

We'll reach out to this number within 24 hrs